WavoDyne Therapeutics Overview
- Founded
-
2014

- Status
-
Out of Business
- Employees
-
1

- Latest Deal Type
-
Out of Business
WavoDyne Therapeutics General Information
Description
Developer of therapeutic treatments designed to help patients suffering from memory impairment. The company's treatments include the development of drugs for memory and cognitive disorders resulting from neuroinflammatory processes, enabling patients to get advanced therapy for their disorders and recover faster.
Contact Information
Website
www.wavodyne.com
Formerly Known As
Camber NeuroTheraputics
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
- Lennox Tech Enterprise Center, 150 Lucius Gordon Drive
- Suite 100
- Rochester, NY 14586
- United States
+1 (954) 000-0000
WavoDyne Therapeutics Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
4. Out of Business | 20-Dec-2017 | Completed | Out of Business | |||
3. Early Stage VC | Completed | Startup | ||||
2. Angel (individual) | 01-Nov-2015 | $50K | Cancelled | Startup | ||
1. Grant | 31-Dec-2014 | $32.4M | Completed | Startup |
WavoDyne Therapeutics Executive Team (1)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Jim New Ph.D | Founder, Chief Executive Officer & Chairman |
WavoDyne Therapeutics Board Members (5)
Name | Representing | Role | Since |
---|---|---|---|
David Klein | Self | Board Member | 000 0000 |
Jim New Ph.D | WavoDyne Therapeutics | Founder, Chief Executive Officer & Chairman | 000 0000 |
Joseph Vacca Ph.D | Self | Board Member | 000 0000 |
Karl Kieburtz MD | Self | Board Member | 000 0000 |